GlassScriptPhysician profile
Doris Mcculley
NPI 1518058148
$2,948.81
in general payments reported to CMS, 2019-2025
15 companies · $748 in 2025
The $748 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $133 · 2021: $119 · 2022: $146 · 2023: $711 · 2024: $715 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $713.72 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $627.01 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $601.89 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $145.60 | 2025 | Capvaxive, M-M-R II, Rotateq |
| Pfizer INC. | $144.34 | 2023-2025 | |
| Glaxosmithkline, LLC. | $142.99 | 2023-2025 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $121.74 | 2020-2025 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $118.58 | 2025 | Livdelzi |
| Exact Sciences Corporation | $95.07 | 2024-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $79.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.80 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $37.00 | 2023-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $35.46 | 2020-2023 | Xarelto |
| Abbott Laboratories | $18.85 | 2023 | Freestyle Libre 3 |
| Amgen INC. | $15.79 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Mcculley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.